Anagrelide and idarubicin combination induces GSDME-mediated pyroptosis as a potential therapy for high-PDE3A acute myeloid leukemia.
Yang C, Hu Y, Gao L, Li Z, Zhang Y, Zhuo R, Du Y, Liu H, Ji Q, Liu M, Pan J, Lu J, Xiao P, Tian Y, He S, Ling J, Hu S.
Yang C, et al. Among authors: liu h, liu m.
Leukemia. 2024 Oct 15. doi: 10.1038/s41375-024-02437-x. Online ahead of print.
Leukemia. 2024.
PMID: 39406931